The DOI matches its Crossref record; 398 of the 398 references it cites were found in a registry or an index.
Microtubules, microtubule-interfering agents and apoptosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–398 of 398
Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
Page, C., Lin, H., Jin, Y. H., et al. (2000) · PubMed · Cited by 220
Long, B. H., Carboni, J. M., Wasserman, A. J., CORNELL, L., Casazza, A. M., Jensen, P. R., Lindel, T., Fenical, W., & Fairchild, C. R. (1998) · PubMed · Cited by 218
Wang, T.-H., Popp, D. M., Wang, H.-S., Saitoh, M., Mural, J. G., Henley, D. C., Ichijo, H., & Wimalasena, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8208 · Cited by 216
Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
Smith, C. D., Zhang, X., Mooberry, S. L., Patterson, G. M. L., & Moore, R. E. (1994) · PubMed · Cited by 216
Microtubule dynamics: taking aim at a moving target
Wilson, L., & Jordan, M. A. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90119-1 · Cited by 215
Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells
Ranganathan, S., Benetatos, C., Colarusso, P., Dexter, D., & Hudes, G. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.91 · Cited by 214
Tryprostatin A, a specific and novel inhibitor of microtubule assembly
USUI, T., KONDOH, M., CUI, C.-B., MAYUMI, T., & OSADA, H. (1998) · Biochemical Journal · doi:10.1042/bj3330543 · Cited by 212
Increased MAPK Expression and Activity in Primary Human Hepatocellular Carcinoma
Schmidt, C. M., McKillop, I. H., Cahill, P. A., & Sitzmann, J. V. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6840 · Cited by 212
The plakin family: versatile organizers of cytoskeletal architecture
Ruhrberg, C., & Watt, F. M. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80154-2 · Cited by 212
Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin/Op18
Andersen, S. S. L. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01786-4 · Cited by 210
Long, B. H., & Fairchild, C. R. (1994) · PubMed · Cited by 209
Wheatley, S. P. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.4.981 · Cited by 209
Targeting tumour vasculature: the development of combretastatin A4
Griggs, J., Metcalfe, J. C., & Hesketh, R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00224-2 · Cited by 207
Chen, J., Wu, W., Tahir, S. K., Kroeger, P. E., Rosenberg, S. H., Cowsert, L. M., Bennett, F., Krajewski, S., Krajewska, M., Welsh, K., et al. (2000) · Neoplasia · doi:10.1038/sj.neo.7900091 · Cited by 207
Kidd, J. F., Pilkington, M. F., Schell, M. J., Fogarty, K. E., Skepper, J. N., Taylor, C. W., & Thorn, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106802200 · Cited by 205
Survivin as a Radioresistance Factor in Pancreatic Cancer
Asanuma, K., Moriai, R., Yajima, T., Yagihashi, A., Yamada, M., Kobayashi, D., & Watanabe, N. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00906.x · Cited by 205
Ando, T., Kawabe, T., Ohara, H., Ducommun, B., Itoh, M., & Okamoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106460200 · Cited by 202
G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells
Blajeski, A. L., Phan, V. A., Kottke, T. J., & Kaufmann, S. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13275 · Cited by 200
Selective Activation of p38 MAPK Cascade and Mitotic Arrest Caused by Low Level Oxidative Stress
Kurata, S.-I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000308200 · Cited by 199
CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered β-tubulin
Cabral, F., Sobel, M. E., & Gottesman, M. M. (1980) · Cell · doi:10.1016/0092-8674(80)90231-7 · Cited by 198
Lee, L.-F., Li, G., Templeton, D. J., & Ting, J. P.-Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28253 · Cited by 197
Diablo Promotes Apoptosis by Removing Miha/Xiap from Processed Caspase 9
Ekert, P. G., Silke, J., Hawkins, C. J., Verhagen, A. M., & Vaux, D. L. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.3.483 · Cited by 196
Loda, M. F., Capodieci, P., Mishra, R., Yao, H. W., Corless, C. L., Grigioni, W. F., Wang, Y., Magi-Galluzzi, C., & Stork, P. A. (1996) · Europe PMC (PubMed Central) · Cited by 195
André, N., Braguer, D., Brasseur, G., Gonçalvès, A., Lemesle-Meunier, D., Guise, S., Jordan, M. A., & Briand, C. M. (2000) · PubMed · Cited by 195
Larsson, N., Marklund, U., Gradin, H. M., Brattsand, G., & Gullberg, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5530 · Cited by 192
Altmann, K.-H., Wartmann, M., & O’Reilly, T. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00009-3 · Cited by 191
Microtubules, membranes and cytokinesis
Straight, A. F., & Field, C. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00746-6 · Cited by 189
Hamel, E. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90028-x · Cited by 186
Accessory protein regulation of microtubule dynamics throughout the cell cycle
Cassimeris, L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80017-9 · Cited by 184
Taxol induction of p21WAF1 and p53 requires c-raf-1.
Blagosklonny, M. V., Schulte, T. W., Nguyen, P., Mimnaugh, E. G., Trepel, J. B., & Neckers, L. M. (1995) · PubMed · Cited by 182
Bcl-G, a Novel Pro-apoptotic Member of the Bcl-2 Family
Guo, B., Godzik, A., & Reed, J. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005889200 · Cited by 182
Protein phosphatase 2A regulates MPF activity and sister chromatid cohesion in budding yeast
Minshull, J., Straight, A., Rudner, A. D., Dernburg, A. F., Belmont, A., & Murray, A. W. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70784-7 · Cited by 181
P-glycoprotein and resistance to anticancer drugs
Ling, V. (1992) · Cancer · doi:10.1002/1097-0142(19920515)69:10<2603::aid-cncr2820691034>3.0.co;2-e · Cited by 180
Manthey, C. L., Brandes, M. E., Perera, P. Y., & Vogel, S. N. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.7.2459 · Cited by 178
Gajate, C., & Mollinedo, F. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337225 · Cited by 177
Self-citationSackett, D. L. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90044-e · Cited by 177
The role of MAPK pathways in the action of chemotherapeutic drugs
Boldt, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.11.1831 · Cited by 175
Mackay, A. M., Ainsztein, A. M., Eckley, D. M., & Earnshaw, W. C. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.5.991 · Cited by 173
Walker, R. A., Pryer, N., & Salmon, E. D. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.114.1.73 · Cited by 169
Bcl-rambo, a Novel Bcl-2 Homologue That Induces Apoptosis via Its Unique C-terminal Extension
Kataoka, T., Holler, N., Micheau, O., Martinon, F., Tinel, A., Hofmann, K., & Tschopp, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010520200 · Cited by 168
Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells.
Haldar, S. M., Basu, A., & Croce, C. M. (1998) · PubMed · Cited by 166
Shibuya, E. K., & Ruderman, J. V. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.8.781 · Cited by 166
Ojima, I., Slater, J. C., Michaud, E., Kuduk, S. D., Bounaud, P.-Y., Vrignaud, P., Bissery, M.-C., Veith, J. M., Pera, P., & Bernacki, R. J. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9604080 · Cited by 165
Characterization of the Taxol Binding Site on the Microtubule
Rao, S., He, L., Chakravarty, S., Ojima, I., Orr, G. A., & Horwitz, S. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37990 · Cited by 164
MAP Kinase Signaling Specificity
Weston, C. R., Lambright, D. G., & Davis, R. J. (2002) · Science · doi:10.1126/science.1073344 · Cited by 163
Huang, Y., Johnson, K. R., Norris, J. S., & Fan, W. (2000) · PubMed · Cited by 163
Noda, Y., Okada, Y., Saito, N., Setou, M., Xu, Y., Zhang, Z., & Hirokawa, N. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108042 · Cited by 163
Attachment and tension in the spindle assembly checkpoint
Zhou, J., Yao, J., & Joshi, H. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.00029 · Cited by 162
Dynamic instability of microtubules
Cassimeris, L. U., Walker, R. A., Pryer, N. K., & Salmon, E. D. (1987) · BioEssays · doi:10.1002/bies.950070403 · Cited by 162
Vaishampayan, U. N., Glodé, M., Du, W., Kraft, A. S., Hudes, G. R., Wright, J. D., & Hussain, M. (2000) · PubMed · Cited by 160
Zhang, C. C., Yang, J.-M., White, E., Murphy, M., Levine, A., & Hait, W. N. (1998) · Oncogene · doi:10.1038/sj.onc.1201658 · Cited by 159
Villunger, A., Scott, C. L., Bouillet, P., & Strasser, A. (2003) · Blood · doi:10.1182/blood-2002-07-2132 · Cited by 158
Complex formation between Mad1p, Bub1p and Bub3p is crucial for spindle checkpoint function
Brady, D. M., & Hardwick, K. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00515-7 · Cited by 155
The pool of map kinase associated with microtubules is small but constitutively active.
Morishima‐Kawashima, M., & Kosik, K. S. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.6.893 · Cited by 152
Expression of survivin and Bcl-2 in the normal human endometrium
Konno, R. (2000) · Molecular Human Reproduction · doi:10.1093/molehr/6.6.529 · Cited by 152
Shtil, A. A., Mandlekar, S., Yu, R., Walter, R. J., Hagen, K. L., Tan, T., Roninson, I. B., & Kong, A. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202305 · Cited by 151
BIRinging Chromosomes through Cell Division—And Survivin' the Experience
Reed, J. C., & Bischoff, J. R. (2000) · Cell · doi:10.1016/s0092-8674(00)00076-3 · Cited by 151
A β-Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel Resistance
Gonzalez‐Garay, M. L., Chang, L., Cabral, F., Blade, K. L., & Menick, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23875 · Cited by 150
Estramustine depolymerizes microtubules by binding to tubulin.
Dahllöf, B., Billström, A., Cabral, F., & Hartley‐Asp, B. (1993) · PubMed · Cited by 148
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
Debernardis, D., Siré, E. G., de Feudis, P., Vikhanskaya, F., Valenti, M., Russo, P., Parodi, S., D’Incalci, M., & Broggini, M. (1997) · PubMed · Cited by 146
Bcl-B, a Novel Bcl-2 Family Member That Differentially Binds and Regulates Bax and Bak
Ning, K., Godzik, A., & Reed, J. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000871200 · Cited by 146
Fltzgerald, T. J. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90108-8 · Cited by 145
Colchicine Induces Apoptosis in Cerebellar Granule Cells
Bonfoco, E., Ceccatelli, S., Manzo, L., & Nicotera, P. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1147 · Cited by 143
The Microtubule-destabilizing Activity of Metablastin (p19) Is Controlled by Phosphorylation
Horwitz, S. B., Shen, H. J., He, L., Dittmar, P., Neef, R., Chen, J., & Schubart, U. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8129 · Cited by 143
Interaction of tubulin with single ring analogs of colchicine
Andreu, J. M., & Timasheff, S. N. (1982) · Biochemistry · doi:10.1021/bi00532a019 · Cited by 142
Tryprostatins A and B, Novel Mammalian Cell Cycle Inhibitors Produced by Aspergdlus fumigatus .
Cui, C., Kakeya, H., Okada, G., Onose, R., Ubukata, M., Takahashi, I., Isono, K., & Osada, H. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.1382 · Cited by 140
Haber, M., Burkhart, C. A., Regl, D. L., Madafiglio, J., Norris, M. D., & Horwitz, S. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31269 · Cited by 139
Leoni, L. M., Hamel, E., Genini, D., Shih, H., Carrera, C. J., Cottam, H. B., & Carson, D. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.217 · Cited by 137
Mitsuuchi, Y., Johnson, S. W., Selvakumaran, M., Williams, S. J., Hamilton, T. C., & Testa, J. R. (2000) · PubMed · Cited by 137
Fan, W. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00006-4 · Cited by 137
Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells
André, N., Carré, M., Brasseur, G., Pourroy, B., Kovacic, H., Briand, C. M., & Braguer, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03691-8 · Cited by 133
Three expressed sequences within the human β-tubulin multigene family each define a distinct isotype
Lewis, S. A., Gilmartin, M. E., Hall, J. L., & Cowan, N. J. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90023-3 · Cited by 133
Moos, P. J., & Fitzpatrick, F. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3896 · Cited by 132
Interaction of tubulin with bifunctional colchicine analogs: an equilibrium study
Andreu, J. M., Gorbunopff, M. J., Lee, J. C., & Timasheff, S. N. (1984) · Biochemistry · doi:10.1021/bi00303a025 · Cited by 131
Hoshi, M. M., Ohta, K., Gotoh, Y., Mori, A., Murofushi, H., Sakai, H., & Nishida, E. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb19825.x · Cited by 131
The Ras-related GTPase Rac1 Binds Tubulin
Best, A., Ahmed, S., Kozma, R., & Lim, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3756 · Cited by 131
Murphy, K. M., Streips, U. N., & Lock, R. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c900590199 · Cited by 130
Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia
Bai, R., Friedman, S., Pettit, G. R., et al. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90153-a · Cited by 129
Ability of the c- mos Product to Associate with and Phosphorylate Tubulin
Zhou, R., Oskarsson, M. S. Z., Paules, R. S., Schulz, N. T., Cleveland, D. W., & Woude, G. F. V. (1991) · Science · doi:10.1126/science.1825142 · Cited by 129
Wendell, K., Wilson, L., & Jordan, M. A. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.2.261 · Cited by 128
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
Majewski, M., Nieborowska-Skorska, M., Salomoni, P., Słupianek, A., Reiss, K., Trotta, R., Calabretta, B., & Skórski, T. (1999) · PubMed · Cited by 126
Adams, R. R., Eckley, D. M., Vagnarelli, P., Wheatley, S. P., Gerloff, D. L., Mackay, A. M., Svingen, P. A., Kaufmann, S. H., & Earnshaw, W. C. (2001) · Chromosoma · doi:10.1007/s004120100130 · Cited by 126
High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.
Tang, C., Willingham, M. C., Reed, J. C., et al. (1994) · PubMed · Cited by 126
Vantieghem, A., Xu, Y. J., Assefa, Z., Piette, J. G., Vandenheede, J. R., Merlevede, W. J., de Witte, P. A. M., & Agostinis, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204348200 · Cited by 124
Okano, J., & Rustgi, A. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011164200 · Cited by 121
McDaid, H. M., & Horwitz, S. B. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.2.290 · Cited by 111
Edelman, M. J. (2003) · Lung Cancer · doi:10.1016/s0169-5002(02)00511-1 · Cited by 109
Marklund, U., Osterman, O., Gradin, H. M., Bergh, A. R. J., & Gullberg, M. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43860-4 · Cited by 106
DISCODERMOLIDE—A NEW, MARINE-DERIVED IMMUNOSUPPRESSIVE COMPOUND: I. IN VITRO STUDIES
LONGLEY, R. E., CADDIGAN, D., HARMODY, D., GUNASEKERA, M., & GUNASEKERA, S. P. (1991) · Transplantation · doi:10.1097/00007890-199110000-00014 · Cited by 104
The dolastatins, a family of promising antineoplastic agents
Poncet, J. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230109214008 · Cited by 104
Mami, U., Miyashita, T., Shikama, Y., Tadokoro, K., & Yamada, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03145-3 · Cited by 102
Jones, N. A., Turner, J., McIlwrath, A. J., Brown, R. E., & Dive, C. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13247-6 · Cited by 102
Mechanism of Action of Cryptophycin
Smith, C. D., & Zhang, X. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6192 · Cited by 101
Herrera, R., Hubbell, S. E., Decker, S. J., & Petruzzelli, L. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3847 · Cited by 101
Caspase-Dependent Cdk Activity Is a Requisite Effector of Apoptotic Death Events
Harvey, K. J., Lukovic, D., & Ucker, D. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.1.59 · Cited by 101
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.
Pitot, H. C., McElroy, E., Reid, J. M., Windebank, A. J., Sloan, J. A., Erlichman, C., Bagniewski, P. G., Walker, D. L., Rubin, J., Goldberg, R. M., et al. (1999) · PubMed · Cited by 101
Zhang, Z., Liu, Q., Lantry, L. E., Wang, Y., Kelloff, G. J., Anderson, M. W., Wiseman, R. W., Lubet, R. A., & You, M. (2000) · PubMed · Cited by 101
Vikhanskaya, F., Vignati, S., Beccaglia, P., Ottoboni, C., Russo, P., D’Incalci, M., & Broggini, M. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4018 · Cited by 96
Reszka, A. A., Bulinski, J. C., Krebs, E. G., & Fischer, E. H. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.7.1219 · Cited by 96
Townsend, K. J., Trusty, J. L., Traupman, M. A., Eastman, A. R., & Craig, R. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202035 · Cited by 96
Bane, S., Puett, D., MACDONALD, T. L., & Williams, R. C. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42801-8 · Cited by 94
Banerjee, A. K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00269-3 · Cited by 94
Apoptotic Cell Death During Treatment of Leukemias
Li, X., Gong, J., Feldman, E. J., Seiter, K. P., Traganos, F., & Darżynkiewicz, Z. (1994) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199409052678 · Cited by 94
Trielli, M. O., Andreassen, P. R., Lacroix, F., & Margolis, R. L. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.3.689 · Cited by 94
2-Methoxyestradiol-Induced Phosphorylation of Bcl-2: Uncoupling from JNK/SAPK Activation
Attalla, H., Westberg, J. A., Andersson, L. C., Adlercreutz, H., & Mäkelä, T. P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8870 · Cited by 94
Retention of the Bub3 checkpoint protein on lagging chromosomes
Martínez-Expósito, M. J., Kaplan, K. B., Copeland, J., & Sorger, P. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8493 · Cited by 93
Menéndez, M., Rivas, G., Díaz, J. F., & Andreu, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.167 · Cited by 91
Mechanism of Action of the Unusually Potent Microtubule Inhibitor Cryptophycin 1
Panda, D., Himes, R. H., Moore, R. E., Wilson, L., & Jordan, M. A. (1997) · Biochemistry · doi:10.1021/bi971302p · Cited by 89
Marine Animal Biosynthetic Constituents For Cancer Chemotherapy
Pettit, G. R., Kamano, Y., Fujii, Y., Herald, C. L., Inoue, M., Brown, P., Gust, D., Kitahara, K., Schmidt, J. M., Doubek, D. L., et al. (1981) · Journal of Natural Products · doi:10.1021/np50016a016 · Cited by 88
Structures of kinesin and kinesin–microtubule interactions
Mandelkow�, E., & Hoenger, A. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80005-2 · Cited by 88
Kottke, T. J., Blajeski, A. L., Martins, L. M., Mesner, P. W., Davidson, N. E., Earnshaw, W. C., Armstrong, D. K., & Kaufmann, S. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15927 · Cited by 88
Barboule, N., Chadebech, P., Baldin, V., Vidal, S., & Valette, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201469 · Cited by 88
In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines
Wagner, M. M. F., Paul, D. C., Shih, C., Jordan, M. A., Wilson, L., & Williams, D. C. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050871 · Cited by 87
The molecular pharmacology of symplostatin 1: A new antimitotic dolastatin 10 analog
Mooberry, S. L., Leal, R. M., Tinley, T. L., Luesch, H., Moore, R. E., & Corbett, T. H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10982 · Cited by 87
Shen, S., Huang, T., Jee, S., & Kuo, M. L. (1998) · PubMed · Cited by 87
Ookata, K., Hisanaga, S., Sugita, M., Okuyama, A., Murofushi, H., Kitazawa, H., Chari, S., Bulinski, J. C., & Kishimoto, T. (1997) · Biochemistry · doi:10.1021/bi971251w · Cited by 86
Blokhin, A. V., Yoo, H., Geralds, R. S., Nagle, D. G., Gerwick, W. H., & Hamel, E. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10502-6 · Cited by 86
Nicoletti, M. I., Valoti, G., Giannakakou, P., Zhan, Z., Kim, J. H., Lucchini, V., Landoni, F., Mayo, J. G., Giavazzi, R., & Fojo, T. (2001) · PubMed · Cited by 85
Gajate, C., Santos-Beneit, A. M., Modolell, M., & Mollinedo, F. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.602 · Cited by 85
Self-citationMicrotubule antagonists activate programmed cell death (apoptosis) in cultured rat hepatocytes.
Tsukidate, K., Yamamoto, K., Snyder, J. W., & Farber, J. L. (1993) · PubMed · Cited by 84
Symplostatin 3, a New Dolastatin 10 Analogue from the Marine Cyanobacterium Symploca sp. VP452
Luesch, H., Yoshida, W. Y., Moore, R. E., Paul, V. J., Mooberry, S. L., & Corbett, T. H. (2001) · Journal of Natural Products · doi:10.1021/np010317s · Cited by 84
Jaffrézou, J., Dumontet, C., Derry, W. B., Durán, G. E., Chen, K. G., Tsuchiya, E., Wilson, L., Jordan, M. A., & Sikic, B. I. (1995) · PubMed · Cited by 82
Margolin, K. A., Longmate, J., Synold, T. W., Gandara, D. R., Weber, J. S., Gonzalez, R. C., Johansen, M. J., Newman, R. A., Baratta, T., & Doroshow, J. H. (2001) · Investigational New Drugs · doi:10.1023/a:1010626230081 · Cited by 82
Andreu, J. M., Perez-Ramirez, B., Gorbunoff, M. J., Ayala, D., & Timasheff, S. N. (1998) · Biochemistry · doi:10.1021/bi9728553 · Cited by 82
Basu, A., & Haldar, S. M. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.4.659 · Cited by 81
Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
Ibrado, A. M., Huang, Y., Fang, G., & Bhalla, K. N. (1996) · PubMed · Cited by 80
Differential Cytostatic and Apoptotic Effects of Ecteinascidin-743 in Cancer Cells
Gajate, C., An, F., & Mollinedo, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204644200 · Cited by 79
Self-citationChromosome Dynamics: New Light on Aurora B Kinase Function
Shannon, K. B., & Salmon, E. D. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00945-4 · Cited by 79
Lu, Q., Hanby, A. M., Hajibagheri, M. A. N., Gschmeissner, S. E., Lu, P., Taylor‐Papadimitriou, J., Krajewski, S., Reed, J. C., & Wright, N. A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.2.363 · Cited by 79
Role of KIFC3 motor protein in Golgi positioning and integration
Xu, Y., Takeda, S., Nakata, T., Noda, Y., Tanaka, Y., & Hirokawa, N. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202058 · Cited by 78
The c-mos gene product is required for cyclin B accumulation during meiosis of mouse eggs.
O’Keefe, S. J., Kiessling, A. A., & Cooper, G. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7869 · Cited by 78
A characterization of cytostatic factor activity from Xenopus eggs and c-mos-transformed cells.
Daar, I. O., Paules, R. S., & Woude, G. F. V. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.114.2.329 · Cited by 77
TZT‐1027, an Antimicrotubule Agent, Attacks Tumor Vasculature and Induces Tumor Cell Death
Otani, M., Natsume, T., Watanabe, J., Kobayashi, M., Murakoshi, M., Mikami, T., & Nakayama, T. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb01022.x · Cited by 76
Interaction of cryptophycin 1 with tubulin and microtubules
Kerksiek, K. M., Mejillano, M. R., Schwartz, R. E., Georg, G. I., & Himes, R. H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01271-0 · Cited by 75
Cell cycle: Regulatory events in G1 → S transition of mammalian cells
Reddy, G. P. V. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240540404 · Cited by 75
Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides
Shih, C., & Teicher, B. A. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397474 · Cited by 74
Three-dimensional structures of proteins involved in programmed cell death
Liang, H., & Fesik, S. W. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1415 · Cited by 74
Stearns, M. E., Wang, M., Tew, K. D., & Binder, L. I. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.6.2647 · Cited by 73
Gajate, C., An, F., & Mollinedo, F. (2003) · PubMed · Cited by 72
Self-citationHow taxol modulates microtubule disassembly.
Caplow, M., Shanks, J., & Ruhlen, R. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31528-4 · Cited by 72
Gajate, C., Barasoaı́n, I., Andreu, J. M., & Mollinedo, F. (2000) · PubMed · Cited by 72
Self-citationMicrotubule disassembly delays the G2–M transition in vertebrates
Rieder, C. L., & Cole, R. W. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00678-3 · Cited by 72
Interaction of estramustine phosphate with microtubule‐associated proteins
Wallin, M., Deinum, J., & Fridén, B. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80536-6 · Cited by 71
Moos, P. J., & Fitzpatrick, F. A. (1998) · PubMed · Cited by 71
Blagosklonny, M. V., Chuman, Y., Bergan, R. C., & Fojo, T. (1999) · Leukemia · doi:10.1038/sj.leu.2401449 · Cited by 71
DISCODERMOLIDE—A NEW, MARINE-DERIVED IMMUNOSUPPRESSIVE COMPOUND
Longley, R. E., CADDIGAN, D., Harmody, D. K., Gunasekera, M., & Gunasekera, S. P. (1991) · Transplantation · doi:10.1097/00007890-199110000-00015 · Cited by 71
Induction of apoptosis by cryptophycin 1, a new antimicrotubule agent
Mooberry, S. L., Busquets, L., & Tien, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3<440::aid-ijc20>3.0.co;2-f · Cited by 70
Liu, Q.-Y., & Stein, C. A. (1997) · PubMed · Cited by 70
Ibrado, A. M., Kim, C. N., & Bhalla, K. N. (1998) · Leukemia · doi:10.1038/sj.leu.2401218 · Cited by 70
Kallio, M. J., Nieminen, M., & Eriksson, J. (2001) · The FASEB Journal · doi:10.1096/fj.01-0280fje · Cited by 69
The mitotic spindle checkpoint
Gorbsky, G. J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00609-1 · Cited by 68
Catastrophic revelations about Op18/stathmin
Belmont, L. D., Mitchison, T. J., & Deacon, H. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(96)30021-2 · Cited by 68
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer
Krug, L. M., Miller, V. A., Kalemkerian, G. P., Kraut, M., Ng, K., Heelan, R. T., Pizzo, B. A., Perez, W., McClean, N., & Kris, M. G. (2000) · Annals of Oncology · doi:10.1023/a:1008349209956 · Cited by 66
Serine 16 of Oncoprotein 18 is a Major Cytosolic Target for the Ca2+/Calmodulin‐Dependent Kinase‐Gr
Marklund, U., Larsson, N., Brattsand, G., Osterman, O., Chatila, T. A., & Gullberg, M. H. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00053.x · Cited by 66
Liu, J.-W., Chandra, D., Tang, S.-H., Chopra, D. P., & Tang, D. G. (2002) · PubMed · Cited by 64
Phase II Study of Dolastatin-10 as First-Line Treatment for Advanced Colorectal Cancer
Saad, E. D., Kraut, E. H., Hoff, P. M., Moore, D. F., Jones, D., Pazdur, R., & Abbruzzese, J. L. (2002) · American Journal of Clinical Oncology · doi:10.1097/00000421-200210000-00005 · Cited by 64
Rey, I., Taylor-Harris, P. M., van Erp, H., & Hall, A. (1994) · PubMed · Cited by 64
Roth, W., Wagenknecht, B., Grimmel, C., DICHGANS, J., & Weller, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.64 · Cited by 63
Harvey, K. J., Blomquist, J. F., & Ucker, D. S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2912 · Cited by 63
hBUB1 defects in leukemia and lymphoma cells
Ru, H. Y., Chen, R., Lu, W. C., & Chen, J. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205585 · Cited by 62
Bitangcol, J. C., Chau, A. S.-S., Stadnick, E., Lohka, M. J., Dicken, B. J., & Shibuya, E. K. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.2.451 · Cited by 61
Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells
Lieu, C., Chang, Y.-N., & Lai, Y. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)82450-1 · Cited by 61
Astral microtubules monitor metaphase spindle alignment in fission yeast
Oliferenko, S., & Balasubramanian, M. K. (2002) · Nature Cell Biology · doi:10.1038/ncb861 · Cited by 60
Binding of E-MAP-115 to microtubules is regulated by cell cycle-dependent phosphorylation.
Masson, D., & Kreis, T. E. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.4.1015 · Cited by 60
Heterodimerization with Bax is Required for Bcl-2 to Repress Cell Death
Yin, X., Oltvai, Z. N., & Korsmeyer, S. J. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79275-5_38 · Cited by 57
Wang, J. M., Chertov, O., Proost, P., Li, J. J., Menton, P., Xu, L., Sozzani, S., Mantovani, A., Gong, W., Schirrmacher, V., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980316)75:6<925::aid-ijc16>3.0.co;2-1 · Cited by 56
Walsh, S., Margolis, S. S., & Kornbluth, S. A. (2003) · PubMed · Cited by 56
Engelborghs, Y., & FitzGerald, T. J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61174-3 · Cited by 55
Koıstınaho, J., Hicks, K. J., & Sagar, S. M. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340213 · Cited by 55
Involvement of Nuclear Factor κB in c-Myc Induction by Tubulin Polymerization Inhibitors
Bourgarel‐Rey, V., Vallée, S., Rimet, O., Champion, S., Braguer, D., Desobry, A., Briand, C. M., & Barra, Y. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12576-x · Cited by 54
Immunosuppression by Discodermolide
Longley, R. E., Gunasekera, S. P., Faherty, D. A., McLane, J. A., & Dumont, F. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17145.x · Cited by 54
Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer
Kerbrat, P., Dieras, V. C., Pavlidis, N. A., Ravaud, A., Wanders, J., & Fumoleau, P. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00531-2 · Cited by 53
Martineau-Thuillier, S. X. E. P., Andreassen, P. R., & Margolis, R. L. (1998) · Chromosoma · doi:10.1007/s004120050330 · Cited by 52
Direct addition of BimL to mitochondria does not lead to cytochrome c release
Terradillos, O., Montessuit, S., Huang, D. C. S., & Martinou, J. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02871-5 · Cited by 51
Interleukin-3 Induces the Phosphorylation of a Distinct Fraction of Bcl-2
Poommipanit, P. B., Chen, B., & Oltvai, Z. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.1033 · Cited by 50
Toxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance
Mirsalis, J. C., Schindler‐Horvat, J., Hill, J. R., Tomaszewski, J. E., Donohue, S. J., & Tyson, C. A. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050995 · Cited by 49
Tan, G., Li, H., Jiang-bo, C., Ming, J., Yanhong, M., Xianghe, L., Hong, S. M., & Li, G. (2001) · International Journal of Cancer · doi:10.1002/ijc.1591 · Cited by 49
Brewton, L. S., Haddad, L. B., & Azmitia, E. C. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02519-7 · Cited by 49
Shearwin, K. E., & Timasheff, S. N. (1994) · Biochemistry · doi:10.1021/bi00170a007 · Cited by 48
Distinct binding and cellular properties of synthetic (+)- and (-)-discodermolides
Hung, D. T., Nerenberg, J. B., & Schreiber, S. L. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90042-6 · Cited by 42
Association of mitogen-activated protein kinases with microtubules in mouse macrophages.
Ding, A. H., Chen, B., Fuortes, M. G., & Blum, E. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1899 · Cited by 40
Ferlini, C., Distefano, M., Pignatelli, F., Lin, S., Riva, A., Bombardelli, E., Mancuso, S., Ojima, I., & Scambia, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1500 · Cited by 39
Preclinical anticancer activity of cryptophycin-8.
Corbett, T. H., Valeriote, F. A., Demchik, L. L., et al. (1996) · PubMed · Cited by 39
Novel Cryptophycin Antitumor Agents: Synthesis and Cytotoxicity of Fragment “B” Analogues
Patel, V. F., Andis, S. L., Kennedy, J. H., Ray, J. E., & Schultz, R. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980706s · Cited by 38
Mollinedo, F., Nieto, J. M., & Andreu, J. M. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09643-9 · Cited by 35
Self-citationPathak, S., Multani, A. S., Ozen, M., Richardson, M. A., & Newman, R. A. (1998) · Oncology Reports · doi:10.3892/or.5.2.373 · Cited by 32
Verdier‐Pinard, P., Sitachitta, N., Rossi, J. V., Sackett, D. L., Gerwick, W. H., & Hamel, E. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1363 · Cited by 32
Wang, X. M., Yew, N. S., Peloquin, J. G., Woude, G. F. V., & Borisy, G. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8329 · Cited by 32
Submicromolar paclitaxel induces apoptosis in human gastric cancer cells at early G1 phase.
Hl, L., Chang, Y.-F., Ty, L., Cw, W., & Cw, C. (1998) · PubMed · Cited by 31
Inhibition of prostate cancer growth by estramustine and colchicine
Fakih, M., Replogle‐Schwab, T. S., Lehr, J. E., Pienta, K. J., & Yagoda, A. (1995) · The Prostate · doi:10.1002/pros.2990260606 · Cited by 30
Fukasawa, K., Rulong, S., Resau, J., Silva, P. P. D., & Woude, G. F. V. (1995) · PubMed · Cited by 30
Rapid completion of mitosis and cytokinesis in PtK cells following release from nocodazole arrest.
Hamilton, B. T., & Snyder, J. A. (1982) · PubMed · Cited by 29
Moraga, D., Rivas-Berrios, A., Farias, G. A., Wallin, M., & Maccioni, R. B. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90342-b · Cited by 28
Mooberry, S. L., Taoka, C. R., & Busquets, L. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04342-x · Cited by 28
Pape, M., Schnieder, T., & von Samson‐Himmelstjerna, G. (2002) · Journal of Parasitology · doi:10.1645/0022-3395(2002)088[0673:iodaio]2.0.co;2 · Cited by 20
Sangrajrang, S., Calvo, F. M., & Fellous, A. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00272-9 · Cited by 13
Vallbo, C., Bergenheim, T. A., Hedman, H., et al. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1014562503097 · Cited by 11
Clinical trials referral resource. Clinical trials of dolastatin-10.
Jj, W., Blatner, G. L., & Cheson, B. D. (1999) · PubMed · Cited by 10
Cited by
Microtubules and resistance to tubulin-binding agents
Kavallaris, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2803 · Cited by 1,120
Stuck in Division or Passing through
Rieder, C. L., & Maiato, H. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.002 · Cited by 657
Targeting Microtubules by Natural Agents for Cancer Therapy
Mukhtar, E., Adhami, V. M., & Mukhtar, H. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0791 · Cited by 565
Taxanes, microtubules and chemoresistant breast cancer
McGrogan, B. T., Gilmartin, B., Carney, D. N., & McCann, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.004 · Cited by 535
Drugs that target dynamic microtubules: A new molecular perspective
Stanton, R. A., Gernert, K. M., Nettles, J. H., & Aneja, R. (2011) · Medicinal Research Reviews · doi:10.1002/med.20242 · Cited by 526
Metadata
- Authors
- Mollinedo, F., & Gajate, C.
- Venue
- Apoptosis
- Published
- 2003-10
- Volume
- 8
- Issue
- 5
- Pages
- 413-450
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W1591187753
- Cited by
- 477
- References
- 398
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.